Speakers
Philip T. Sager, MD
Adjunct Professor, Stanford University, United States
Philip T. Sager, M.D, FACC, FAHA, FHRS is an Adjunct Professor at the Stanford University, the previous chair of the FDA Cardio-Renal Advisory Committee and an Executive Comm. member of the Cardiac Safety Research Consortium. He is a member of the ICH E14 QT Group and is on the Steering Comm, Comprehensive In Vitro Proarrhythmia Assay effort. He holds an M.D. from Yale University and B.S. degrees in biology and chemistry from the MIT and has published more than 200 manuscripts and abstracts.
William B White, MD, FACC
Professor of Medicine and Division Chief, Hypertension and Clinical Pharmacology, University of Connecticut School of Medicine, United States
Michael A. Weber, MD, FACC
Professor of Medicine, State University of New York, United States
Have an account?